, , ,

<<


 >>  ()
Pages:   || 2 | 3 | 4 | 5 |   ...   | 8 |
-- [ 1 ] --

616-006-053.2-07-08

. 3 . . 2.

/

.. [ .]. - : , 2 0 0 7. - 2 4 4 . -

ISBN 978-985-6744-37-5.

, , , , , , - . , -736 - , - .

- , , -, , , , .

. 2 0 0, . 3 1, . 308 .

, , - .

:

.. , .. , .. , .. , .. , .. :

, .. , , .. - , - , . . I S B N 9 7 8 - 9 8 5 - 6 7 4 4 - 3 7 - 5 ( . 2) . ISBN 978-985-6744-23-8 , , 1. ( . , .. , . . ) 1.1. 1.2. (.. ) (.. ) (.. ) - ( . , A.M. , . ) 1.3. 1.3.1. (.. ) (. )... - (.. , A. M. ) ( . ) (.. ) 1.3.2. (.. ) (.. ). - (.. , A. M. ) 2. ( . , .. ) 2.1. 2.2. , 2.2.1. / (.. , .. ) - (.. , A. M. ) - (.. , .. ) 2.2.2. (.. , .. ) - (. , A. M. ) - (.. , .. ) 2.2.3. ( . . , .. ) - (.. , A. M. ) - (.. , .. ) 2.2.4. (.. , .. ) - ( , A. M. ) - (.. , .. ) 2.2.5. (.. , .. ) - (.. , .. ) 2.3. 3. (.. , .. , .. , .. ) 3.1. (.. , .. , .. , .. ) 3.1.1. 3.1.2. 3.1.3. 3.1.4. - 3.1.5. 3.2. (.. , .. , . , . , . ) 3.2.1. 3.2.2. .. 3.2.3. - » 1. 1.1. 1.2. 1.3. 2. 3. 3.1. 3.2 .. 3.3. , 3.4. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 - - --3 - - - - - - - - - - - - - () - () - - - - - - - - - - - - - - - - - - - - A T R A - all t r a n s retinoic acid ( ) A S R - a g e - s t a n d a r t i z i d e rate ( ) C G H - c o m p a r a t i v e g e n o m i c hybridization ( ) I C C C - International C l a s s i f i c a t i o n of C h i l d h o o d C a n c e r ( ) I C D - 0 - International Classification of D i s e a s e s for O n c o l o g y ( ) E G F R - e p i d e r m a l g r o w t h factor receptor ( ) FAB- - French-American-British (--) F I S H - f l u o r e s c e n c e in situ hibridisation ( in-situ ) Follow-up - L O H - loss of h e t e r o z y g o c i t y ( ) P A S - p e r i o d i c acid shift reaction - - R E A L - r e v i s e d E u r o p e a n - A m e r i c a n l y m p h o m a classification ( - ) TCR - - , , : , 70 % .

, - .

, - . , .

, , - () , , - .

:

1. , - .

2. .

3. .

4. .

( , ) ( , - ) , , - :

- - (- -, , );

- .

, , ( 1), ( 2), ( 3), .

.

I (). .

II (-) ( ;

-;

).

III. .

, , , .

, -1489 , 2 0 0 6 - 2 0 1 0 .:

- 5-01. ;

- 5-02. .

30 2 0 % [ 1, 2]. (. 1) [3-5]. , - ( . 2), , , - , ( . 3).

0% 5 10 V. 15 /. 20 V. 25 " 30 " . 1. 1990-2004 ., % [ 1, 2]. , S E E R ( S u r v e i l l a n c e, E p i d e m i o l o g y a n d E n d Results)-nporpaMMOH, , 2,8 100 . ( 2 10 ) (31 ) [3, 4 ]. 19-22 % [5].

/. 30% 20 % 25"/.

15 % . 2. 1990-2004 ., % % 5% 10 % 15% 20% 25% ]22, 20, 122, , 0, \. 2, 00, . 3. 1990-2004 ., % - 3 ( . 1, 2) - - 3, , - [6-9].

, , .

(-3, 2005) [10] I:

, -- 9820, 9823, 9826, 9827, 9831-9837, 9940, l.a. 9840, 9861, 9866, 9867, 9870-9874, 9 8 9 1.

l.b. 9895-9897, 9910, 9920, I.e. 9863, 9875, 9876, 9950, 9960- l.d. 9945, 9946, 9975, 9980, 9982-9987, I.e. 9800, 9 8 0 1, 9805, 9860, (ICCC-3, 2005) [10] III:

-- III.. 9383,9390,9391,9392, 9380, 9384. 9400, 9 4 0 1, 9410, 9 4 1 1, 9420, .. 9421, 9423, 9424, 9440, 9 4 4 1, 9442, III.. 9470, 9 4 7 1, 9472, 9473, 9474, 9480, 9508, 9 5 0 1, 9 5 0 2, 9 5 0 3. 9380, 9 3 8 1, 9382, 9430, 9444, 9450, 9451, lll.d. 8270, 8 2 7 1, 8272, 8280, 8 2 8 1, 8300, 9350, 9351, 9352, 9360, 9 3 6 1, 9362, 9412, 9413, .. 9492, 9493, 9505, 9506, 9507, 9530, 9531, 9532, 9533, 9534, 9535, 9537, 9538, 9539, 9582, lll.f. 8000, 8001, 8002, 8003, 8004, 1. A s y s t e m of provision, p r e s e n t a t i o n a n d i n t e r p r e t a t i o n of d a t a o n cancer inci d e n c e a n d s u r v i v a l of c h i l d r e n a n d a d o l e s c e n t s in E u r o p e // A u t o m a t e d C h i l d h o o d C a n c e r I n f o r m a t i o n S y s t e m ( A C C I S ) [Electronic r e s o u r c e ]. - M o d e of a c c e s s :

http : / / w w w - d e p. i a rc. f r/accis. ht m.

2. C a n c e r s u r v e i l l a n c e series: recent t r e n d s in c h i l d h o o d c a n c e r i n c i d e n c e a n d m o r t a l i t y in t h e United S t a t e s / M. Linet [et al.] // J o u r n a l o f t h e N a t i o n a l C a n c e r Insti tute. - 2 0 0 3. - V o l. 9 1 ( 1 2 ). - P. 1 0 5 1 - 1 0 5 8.

3. , . / . , . . . - : , 2 0 0 4. - 170 .

4. , .. 1989 2 0 0 3 / . . , .. , . . // : : . . . II . , ., , 2 6 - 2 7 2 0 0 4 . - , 2 0 0 4. - . 10-12.

5. I n t e r n a t i o n a l I n c i d e n c e of C h i l d h o o d C a n c e r : I A R C Scientific Publications / D. P a r k i n [et al.]. - L y o n, 1998. - 144 p.

6. M a t h e, G. Histological a n d cytological t y p i n g of n e o p l a s t i c d i s e a s e s h e a m a topoietic a n d l y m p h o i d t i s s u e s. International h i s t o l o g i c a l classification of t u m o u r s / G. M a t h e, H. R a p p a p o r t. - G e n e v a : W o r l d Health O r g a n i z a t i o n, 1976. - N o. 14.

7. P r o p o s a l s for the classification o f t h e a c u t e l e u k e m i a s. F r e n c h - A m e r i c a n British ( F A B ) C o o p e r a t i v e G r o u p / J. M. B e n n e t [et al.] // Br. J. H a e m a t o l. - 1976. Vol. 3 3. - P. 451-458.

8. W o r l d Health O r g a n i z a t i o n Classification of T u m o u r s : Pathology a n d G e n e t ics of T u m o u r s of H a e m a t o p o i e t i c a n d L y m p h o i d T i s s u e s / E. Jaffe [et al.]. - F r a n c e, L y o n : I A R C P r e s s, 2 0 0 1. - 2 0 0 p.

9. V a r d i m a n, J.W. T h e W o r l d H e a l t h O r g a n i z a t i o n ( W H O ) classification of the m y e l o i d n e o p l a s m s / J.W. V a r d i m a n, N.L. Harris, R.D. B r u n n i n g // B l o o d. - 2 0 0 2. Vol. 1 0 0. - P. 2292-2302.

10. I n t e r n a t i o n a l Classification of C h i l d h o o d C a n c e r, T h i r d Edition / E. Stela r o v a - F o u c h e r [et al.] // C a n c e r. - 2 0 0 5. - V o l. 1 0 3. - N o. 7. - P. 1 4 5 7 - 1 4 6 7.

1. 1.1. , , . , 14 .

80 % , - 15 % [1], - 79 1 5 % [ 2, 3]. [ 4, 5].

1-4 , , . , , [5].

( ) , , , , : , , . [6-9]. , , . 1990 1999 . [4, 5] 1990 1999 . 2000 2004 . [10] . 3. ( - 44,9 1 ;

10,6 1 ;

- 58,4 1 ), [11].

( ASR) 1 (0-14 ) , 1990-1999 . 1990- 2000 1999 . 2004 .

44,1 40, 45,1 39,2 48,5 43,3 43,6 38, 36,8 31,4 40,3 35,2 35,8 35,9 31,0 31, 7,5 6,9 4,9 6,3 5,8 6,3 4,8 7, 1976 . ( - ) [12], - , ( F A B - ) [13]. ( ) . , , F A B - , .

( 2 0 0 1 ), 100 - [14, 15]. , , - , . , , .

- , R E A L - - , . FAB , P V S G ( P o l y c y t h e m i a V e r a S t u d y G r o u p ) . , , , .

( , ) ( , 2 0 0 1 ) [14] - - / - ( -) () - / - - / - NK- - / - ( - ) () /- - / - - NK- - / : , .

( , ) ( , 2 0 0 1 ) [14] () ct(8;

21)(q22;

q22), AML1/ETO inv(16)(p13q22) t(16;

16)(p13;

q11) (CBF(VMYH11) ct(15;

17)(q22;

q11-12) (PML/RARa) 11q23 (MLL) / / , 50 % ( ) , / (- ) .

, . 4 0 ( ) ( 1 ), 1 0 [ 1 6 ]. (2-10 -2-10 ) 11 . .

[ 1 7, 1 8 ].

, , , , - , , .

( ):

- (, , , , ;

, );

- (, - , );

- (, , , , (- , ), ).

( );

( , , , , , ), , ;

( 5-20 % ) - , , - .

( ) : , , .;

( : , - , ;

: , , , );

: , , ;

;

, , , , ;

( , , ).

: ( , 10-20 % ;

- , 20 / ) ;

( , , );

( , , , ).

- ( ) , , ( , , , , , ).

( ) .

( ), .

) ( - , ), .

.

60- , 8 0 - - , , [ 1 9 - 2 2 ].

A C C I S projects ( I A C R ) 90- X X . 82 %, - 53 % [4, 5]. , . , , , , : , , , , , , , 6 - , 6-. , - . , , [23-26].

, - , , , , [ 2 7 - 2 9 ].

, , - .

DNA-microarrays . , . , DNA microarrays , , , , [ 3 0, 31].

1.2. - .

() - , , ( , , ).

- :

, (), ;

;

- ;

;

( , , , , - , , ) ;

;

, ( , / , .), , .

- , - ;

- ( , , , );

- . (-, - ) () . , , [32];

- . ( G - . . ), ( F I S H, C G H . . ), , ;

- - . IgH T C R , . -, , , . (. 4-7) [33].

. , , , . 4 5 . - 0,3-0,5 .

. 4. . 5. . 6. . 7. [34] 6 2 2 2 - [35] , 3 3- 2-3 4- 4-5 3-4 4-5 5- 6-10 5-6 6-7 7- 11-14 7-8 8-9 9- 15-17 9-10 10-11 11- 12 10-11 12- 11- .

( 2-3 ) .


, , , . , , . , , . , - , . .

( 10, 10) , , . ( ) ( 10, 100).

5 0 0 , - 2 0 0 . [ 1 4 ].

. 6 [36-38].

10-20 14-20 :

, , , ;

;

, , , , , ;

2-5, ;

0-2, ;

, - :

-, - ;

-;

( 20 % ;

);

* | 6 0 - 7 0 % " ' ˻ (. . 60).

" .

. [39, 4 0 ].

( - ). - , . - .

, , . ( ).

. . - . , .

( PAS-). , , - . , - , . , . , .

(-- ). , , , -. , . - . ( ) , , . . , [ 1 4 ]. , - .

[41]. , [ 4 1 - 4 3 ].

- . - - , (. . 12, 1 3, 16), [44-48].

, , - [ 4 9 - 5 1 ].

, , - - [14].

, [52, 53]:

-: CD10, CD19, CD20, CD22, C D 2 4, CD79a, () (s) I g M, - - l g ;

-: CD1a, CD2, CD3, C D 4, C D 5, C D 7, C D 8, T C R ct/p+, T C R /+;


: , CD13, CD33, CDw65, CD117, , CD14, CD15, C D 4 1, C D 6 1, C D 6 4, ;

-: TdT, CD34, HLA-DR;

CD45 ( , ).

, ( - FITC, - , - .).

, , , , , , , , .

, , , . -, . .

- , , ( ), , [54-57]. .

1. , . :

) ( , , IgH/cMYC);

) ( , . . , AML1).

2. . :

) , (BCR/ABL, TEUAML1), ( . fusion) , , . ( SIL/TAL1) (CBFpVMYHH), , ;

) , , . , - .

, , (TEL KIP, 14, 15 16) (15, 16) [ 5 8 ].

, , / . , , , .

- . , , , . : PMURARa ( ), (, MYB, v-erbA), - , [59, 6 0 ]. , PMURARa , , - . . . , - , . , S - .

, , (), . : ( 4 5 ) ;

(46 ) ;

( 4 6 ) ;

( 4 7 - 5 0 ) ;

( 5 0 ) ;

/ ( 6 5 ). (t), (inv), (del), .

- [ 1 4, 15]. . [ 6 1, 62). , : t(9;

22)(q34;

q11), BCR/ABL, 1 1 q 2 3 MLL:

t ( 1 ;

1 9 ) ( q 2 3 ;

p 1 3 ) 2/1, t(12;

21)(p12;

q22) ETV/CBFa (TEUAML1), t(8;

21)(q22;

q22), AML1 (CBFa)/ETO;

t(15;

17)(q22:q11-12) PMURARa : inv16 CBFB/3/MYH11.

TCR. . 8, , - .

Q I ;

2q. CD 2 CD CD 5 CD. m I ( CD -Q 8 8 - 3= .

" " . 8. TCRG - , :

1) . 1 T C R - - - [63].

,

1 T C R. IgHUCR - - - , - [ 6 4 - 6 7 ] ;

2) . , , , . - - 1 T C R [ 6 8 - 7 0 ] ;

3) 1 T C R . , [ 7 1 - 7 5 ].

, , s l g " - T d T - [76-79], .

T C R 1 - [14].

1.3. 1.3.1. , - - - . - (85 %) 15 % - - [ 1 4, 80, 81]. - 10 , - , , ( 5 0 - 1 0 / , , , , ) [82, 8 3 ].

(--3), , . 7.

- , 8 0 % [85-87]. ( 40-46 % 5 0 - 6 5 % ), ( , , ) [88] , , .

, , , - [89]. , 2/1, , , 8 0 % [90]. BCR/ABL, MLL , , [ 9 1, 92].

(-0-3, 2000) [84] 982-983 (42.1) 9820/3 , - 9623/ 9826/3 - 9827/ 9831/1 - , 9832/ 9833/3 , - 9834/3 , - 9835/3 -, - 9836/ 9837/3 - ( L 1, L2 L3) [13, 9 3, 94] ( . . 8) : ;

;

;

;

;

;

;

;

.

L1 , , - . , , , , , , , ( . 9).

L2 . , (, , ), - , , ( . 10-12).

L3 : , , , , (. 13).

. 13. . L3 ;



Pages:   || 2 | 3 | 4 | 5 |   ...   | 8 |
 
 >>  ()





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .